TOLVAPTAN ADMINISTRATION AMONG PATIENTS WITH HEART FAILURE IN JAPANESE NATION WIDE REGISTRY

Tolvaptan, a selective blocker for the vasopressin V2 receptor in the kidney, has been available as a diuretic agent for treatment of heart failure in Japan since 2010. In Japanese guidelines for heat failure, administration of tolvaptan is recommended for patients who show poor response to existing